Concepedia

Publication | Open Access

Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist

49

Citations

28

References

2017

Year

Abstract

NIH, NIAMS, and NIAID.

References

YearCitations

Page 1